Literature DB >> 9297769

Percutaneous nephrolithotripsy in the morbidly obese patient.

G J Faerber1, M Goh.   

Abstract

From 1989 to 1995, 530 patients underwent percutaneous nephrolithotripsy, of which 93 were identified as morbidly obese. A retrospective study was performed comparing results of nephrolithotripsy in patients with near normal ideal body weight versus those patients considered morbidly obese. Outcome parameters measured included size, configuration, and number of calculi, location and number of access sites required, stone-free rates, operative time, number of ancillary procedure, hospital stay, and complications. Stone number was similar between the normal weight and morbidly obese groups; however, the morbidly obese group had smaller stones treated percutaneously. Operative time was similar between the two groups if a single access was required, but then was significantly higher in the morbidly obese group if multiple access sites were necessary. Stone-free rates were not statistically different between normal weight versus obese patients (89% vs. 82%). However, hospital stay was longer (3.5 days vs. 4.4 days) and the overall rate of complications was higher (16% vs. 37%) in the morbidly obese group compared to normal weight group.

Entities:  

Mesh:

Year:  1997        PMID: 9297769

Source DB:  PubMed          Journal:  Tech Urol        ISSN: 1079-3259


  17 in total

1.  Which factors may effect urinary leakage following percutaneous nephrolithotomy?

Authors:  Ayhan Dirim; Tahsin Turunc; Baris Kuzgunbay; Eray Hasirci; Mehmet Ilteris Tekin; Hakan Ozkardes
Journal:  World J Urol       Date:  2010-09-26       Impact factor: 4.226

2.  Effect of body mass index on operative time, hospital stay, stone clearance, postoperative complications, and postoperative analgesic requirement in patients undergoing percutaneous nephrolithotomy.

Authors:  Durre Shohab; Ramsha Ayub; Muhammad Umar Alam; Amna Butt; Sanam Sheikh; Salman Assad; Saeed Akhter
Journal:  Turk J Urol       Date:  2015-12

3.  Obesity and Kidney Stone Procedures.

Authors:  Nikhi P Singh; Carter J Boyd; William Poore; Kyle Wood; Dean G Assimos
Journal:  Rev Urol       Date:  2020

4.  [Effect of the body mass index on outcomes of ureterorenoscopy for renal stones].

Authors:  F Schott; S Knipper; A K Orywal; A J Gross; C Netsch
Journal:  Urologe A       Date:  2016-11       Impact factor: 0.639

5.  The effect of abdominal fat parameters on percutaneous nephrolithotomy success.

Authors:  Ozgur Cakmak; Huseyin Tarhan; Sertac Cimen; Rahmi Gokhan Ekin; Ilker Akarken; Ozgur Oztekin; Ertan Can; Tufan Suelozgen; Yusuf Ozlem Ilbey
Journal:  Can Urol Assoc J       Date:  2016 Mar-Apr       Impact factor: 1.862

6.  Impact of body mass index on clinical outcomes associated with percutaneous nephrolithotomy.

Authors:  Fahad A Alyami; Thomas A A Skinner; Richard W Norman
Journal:  Can Urol Assoc J       Date:  2013-04-16       Impact factor: 1.862

7.  Percutaneous Nephrolithotomy in the Superobese: A Comparison of Outcomes Based on Body Mass Index.

Authors:  Casey A Dauw; Michael S Borofsky; Nadya York; James E Lingeman
Journal:  J Endourol       Date:  2016-08-22       Impact factor: 2.942

8.  Does body mass index effect the success of percutaneous nephrolithotomy?

Authors:  Abdülmuttalip Şimşek; Faruk Özgör; Mehmet Fatih Akbulut; Onur Küçüktopçu; Ahmet Yalçın Berberoğlu; Ömer Sarılar; Murat Binbay; Ahmet Yaser Müslümanoğlu
Journal:  Turk J Urol       Date:  2014-06

9.  Effect of the body mass index on outcomes of flexible ureterorenoscopy.

Authors:  Erhan Sari; Abdulkadir Tepeler; Emrah Yuruk; Berkan Resorlu; Tolga Akman; Murat Binbay; Abdullah Armagan; Ali Unsal; Ahmet Yaser Muslumanoglu
Journal:  Urolithiasis       Date:  2013-07-23       Impact factor: 3.436

10.  Pre- and perioperative predictors of short-term clinical outcomes in patients undergoing percutaneous nephrolitholapaxy.

Authors:  Peter J Olbert; Axel Hegele; Andres J Schrader; André Scherag; Rainer Hofmann
Journal:  Urol Res       Date:  2007-09-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.